{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,8]],"date-time":"2026-06-08T12:39:46Z","timestamp":1780922386341,"version":"3.54.1"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,6,5]],"date-time":"2023-06-05T00:00:00Z","timestamp":1685923200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,6,5]],"date-time":"2023-06-05T00:00:00Z","timestamp":1685923200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100014188","name":"Ministry of Science and ICT, South Korea","doi-asserted-by":"publisher","award":["NRF-2021R1C1C1009815"],"award-info":[{"award-number":["NRF-2021R1C1C1009815"]}],"id":[{"id":"10.13039\/501100014188","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    This retrospective study evaluated the electronic medical records of patients with ankylosing spondylitis (AS) (January 2001\u2013December 2018) to determine the relationship between serum alkaline phosphatase (ALP) levels and radiographic changes over time. Longitudinal data, including serum ALP levels, were imputed by linear interpolation at 3-month intervals. Among the serum ALP levels calculated for 8\u00a0years prior to modified Stoke Ankylosing Spondylitis Spinal Score (mSASSS) measurement, those having the highest beta coefficient with the mSASSS were selected in the correlation between ALP and longitudinal mSASSS. Linear mixed models with the selected serum ALP levels, mSASSS, and clinical variables were investigated. We included 1122 patients (mean follow-up, 8.20 [standard deviation: 2.85] years). The serum ALP level from 5\u00a0years and 3\u00a0months prior showed the highest beta coefficient with the mSASSS. In the linear mixed model, the serum ALP level at 5\u00a0years and 3\u00a0months before radiographic changes was significantly associated with the mSASSS (\u03b2\u2009=\u20090.021, 95% confidence interval: 0.017\u20130.025,\n                    <jats:italic>p<\/jats:italic>\n                    \u2009&lt;\u20090\n                    <jats:italic>.<\/jats:italic>\n                    001). Serum ALP levels measured approximately 5\u00a0years before may be a surrogate marker for predicting spinal radiographic changes. Long-term prospective clinical and experimental studies of\u2009&gt;\u20095\u00a0years are required for biomarker discovery or therapeutic research on AS radiographic progression.\n                  <\/jats:p>","DOI":"10.1038\/s41598-023-36340-9","type":"journal-article","created":{"date-parts":[[2023,6,5]],"date-time":"2023-06-05T05:02:33Z","timestamp":1685941353000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Association between changes in serum alkaline phosphatase levels and radiographic progression in ankylosing spondylitis"],"prefix":"10.1038","volume":"13","author":[{"given":"Tae-Hwan","family":"Kim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seo Young","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ji Hui","family":"Shin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seunghun","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyung Bin","family":"Joo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4212-2634","authenticated-orcid":false,"given":"Bon San","family":"Koo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,6,5]]},"reference":[{"key":"36340_CR1","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1038\/s41584-021-00625-y","volume":"17","author":"D Mauro","year":"2021","unstructured":"Mauro, D. et al. Ankylosing spondylitis: An autoimmune or autoinflammatory disease?. Nat. Rev. Rheumatol. 17, 387\u2013404 (2021).","journal-title":"Nat. Rev. Rheumatol."},{"key":"36340_CR2","doi-asserted-by":"publisher","first-page":"55","DOI":"10.4078\/jrd.2021.28.2.55","volume":"28","author":"RD Inman","year":"2021","unstructured":"Inman, R. D. Axial spondyloarthritis: Current advances, future challenges. J. Rheum. Dis. 28, 55\u201359 (2021).","journal-title":"J. Rheum. Dis."},{"key":"36340_CR3","doi-asserted-by":"publisher","first-page":"1759720X2096926","DOI":"10.1177\/1759720X20969260","volume":"12","author":"G Clunie","year":"2020","unstructured":"Clunie, G. & Horwood, N. Loss and gain of bone in spondyloarthritis: What drives these opposing clinical features?. Ther. Adv. Musculoskelet. Dis. 12, 1759720X20969260 (2020).","journal-title":"Ther. Adv. Musculoskelet. Dis."},{"key":"36340_CR4","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1080\/08820139.2019.1567531","volume":"48","author":"M Chen","year":"2019","unstructured":"Chen, M. et al. Serum levels of OPG, RANKL, and RANKL\/OPG ratio in patients with ankylosing spondylitis: A systematic review and meta-analysis. Immunol. Invest. 48, 490\u2013504 (2019).","journal-title":"Immunol. Invest."},{"key":"36340_CR5","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1016\/j.berh.2014.10.008","volume":"28","author":"RJ Lories","year":"2014","unstructured":"Lories, R. J. & Haroon, N. Bone formation in axial spondyloarthritis. Best Pract. Res. Clin. Rheumatol. 28, 765\u2013777 (2014).","journal-title":"Best Pract. Res. Clin. Rheumatol."},{"key":"36340_CR6","doi-asserted-by":"publisher","first-page":"2126","DOI":"10.3899\/jrheum.100200","volume":"37","author":"HA Chen","year":"2010","unstructured":"Chen, H. A. et al. Association of bone morphogenetic proteins with spinal fusion in ankylosing spondylitis. J. Rheumatol. 37, 2126\u20132132 (2010).","journal-title":"J. Rheumatol."},{"key":"36340_CR7","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1038\/nrneph.2017.60","volume":"13","author":"M Haarhaus","year":"2017","unstructured":"Haarhaus, M., Brandenburg, V., Kalantar-Zadeh, K., Stenvinkel, P. & Magnusson, P. Alkaline phosphatase: A novel treatment target for cardiovascular disease in CKD. Nat. Rev. Nephrol. 13, 429\u2013442 (2017).","journal-title":"Nat. Rev. Nephrol."},{"key":"36340_CR8","doi-asserted-by":"publisher","first-page":"5357","DOI":"10.1172\/JCI125212","volume":"129","author":"CH Liu","year":"2019","unstructured":"Liu, C. H. et al. HLA-B27-mediated activation of TNAP phosphatase promotes pathogenic syndesmophyte formation in ankylosing spondylitis. J. Clin. Invest. 129, 5357\u20135373 (2019).","journal-title":"J. Clin. Invest."},{"key":"36340_CR9","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1007\/s11926-017-0681-5","volume":"19","author":"D Poddubnyy","year":"2017","unstructured":"Poddubnyy, D. & Sieper, J. Mechanism of new bone formation in axial spondyloarthritis. Curr. Rheumatol. Rep. 19, 55 (2017).","journal-title":"Curr. Rheumatol. Rep."},{"key":"36340_CR10","doi-asserted-by":"publisher","first-page":"1328","DOI":"10.3899\/jrheum.220157","volume":"49","author":"BS Koo","year":"2022","unstructured":"Koo, B. S. et al. Relationship between inflammation and radiographic progression in patients with ankylosing spondylitis attaining a BASDAI of <4 during TNF inhibitor treatment. J. Rheumatol. 49, 1328 (2022).","journal-title":"J. Rheumatol."},{"key":"36340_CR11","doi-asserted-by":"publisher","first-page":"1388","DOI":"10.1002\/art.33465","volume":"64","author":"D Poddubnyy","year":"2012","unstructured":"Poddubnyy, D. et al. Baseline radiographic damage, elevated acute-phase reactant levels, and cigarette smoking status predict spinal radiographic progression in early axial spondylarthritis. Arthr. Rheum 64, 1388\u20131398 (2012).","journal-title":"Arthr. Rheum"},{"key":"36340_CR12","first-page":"125","volume":"31","author":"A Spoorenberg","year":"2004","unstructured":"Spoorenberg, A. et al. Radiological scoring methods in ankylosing spondylitis. Reliability and change over 1 and 2 years. J. Rheumatol. 31, 125\u2013132 (2004).","journal-title":"J. Rheumatol."},{"key":"36340_CR13","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1002\/art.1780270401","volume":"27","author":"S van der Linden","year":"1984","unstructured":"van der Linden, S., Valkenburg, H. A. & Cats, A. Evaluation of diagnostic criteria for ankylosing spondylitis. A proposal for modification of the New York criteria. Arthritis Rheum. 27, 361\u2013368 (1984).","journal-title":"Arthritis Rheum."},{"key":"36340_CR14","doi-asserted-by":"publisher","first-page":"e104966","DOI":"10.1371\/journal.pone.0104966","volume":"9","author":"YB Joo","year":"2014","unstructured":"Joo, Y. B. et al. Bone morphogenetic protein 6 polymorphisms are associated with radiographic progression in ankylosing spondylitis. PLoS ONE 9, e104966 (2014).","journal-title":"PLoS ONE"},{"key":"36340_CR15","doi-asserted-by":"publisher","first-page":"R14","DOI":"10.1186\/ar4144","volume":"15","author":"S Ramiro","year":"2013","unstructured":"Ramiro, S. et al. Scoring radiographic progression in ankylosing spondylitis: should we use the modified Stoke Ankylosing Spondylitis Spine Score (mSASSS) or the Radiographic Ankylosing Spondylitis Spinal Score (RASSS)?. Arthritis Res. Ther. 15, R14 (2013).","journal-title":"Arthritis Res. Ther."},{"key":"36340_CR16","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1111\/1756-185X.14268","volume":"25","author":"BS Koo","year":"2022","unstructured":"Koo, B. S. et al. Early control of C-reactive protein levels with non-biologics is associated with slow radiographic progression in radiographic axial spondyloarthritis. Int. J. Rheum. Dis. 25, 311\u2013316 (2022).","journal-title":"Int. J. Rheum. Dis."},{"key":"36340_CR17","doi-asserted-by":"publisher","first-page":"1327","DOI":"10.1136\/annrheumdis-2019-216741","volume":"79","author":"BS Koo","year":"2020","unstructured":"Koo, B. S. et al. Tumour necrosis factor inhibitors slow radiographic progression in patients with ankylosing spondylitis: 18-year real-world evidence. Ann. Rheum. Dis. 79, 1327\u20131332 (2020).","journal-title":"Ann. Rheum. Dis."},{"key":"36340_CR18","doi-asserted-by":"publisher","first-page":"1759720X2097591","DOI":"10.1177\/1759720X20975912","volume":"12","author":"TH Lee","year":"2020","unstructured":"Lee, T. H. et al. Conventional disease-modifying antirheumatic drugs therapy may not slow spinal radiographic progression in ankylosing spondylitis: RESULTS from an 18-year longitudinal dataset. Ther. Adv. Musculoskelet. Dis. 12, 1759720X20975912 (2020).","journal-title":"Ther. Adv. Musculoskelet. Dis."},{"key":"36340_CR19","doi-asserted-by":"publisher","first-page":"305","DOI":"10.3389\/fimmu.2019.00305","volume":"10","author":"WP Maksymowych","year":"2019","unstructured":"Maksymowych, W. P. Biomarkers for diagnosis of axial spondyloarthritis, disease activity, prognosis, and prediction of response to therapy. Front. Immunol. 10, 305 (2019).","journal-title":"Front. Immunol."},{"key":"36340_CR20","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1136\/ard.42.5.563","volume":"42","author":"NJ Sheehan","year":"1983","unstructured":"Sheehan, N. J., Slavin, B. M., Kind, P. R. & Mathews, J. A. Increased serum alkaline phosphatase activity in ankylosing spondylitis. Ann. Rheum. Dis. 42, 563\u2013565 (1983).","journal-title":"Ann. Rheum. Dis."},{"key":"36340_CR21","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/S0009-9120(89)80009-8","volume":"22","author":"WH Siede","year":"1989","unstructured":"Siede, W. H., Seiffert, U. B., Merle, S., Goll, H. G. & Oremek, G. Alkaline phosphatase isoenzymes in rheumatic diseases. Clin. Biochem. 22, 121\u2013124 (1989).","journal-title":"Clin. Biochem."},{"key":"36340_CR22","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1016\/j.semarthrit.2015.03.002","volume":"45","author":"KY Kang","year":"2015","unstructured":"Kang, K. Y., Hong, Y. S., Park, S. H. & Ju, J. H. Increased serum alkaline phosphatase levels correlate with high disease activity and low bone mineral density in patients with axial spondyloarthritis. Semin. Arthritis Rheum. 45, 202\u2013207 (2015).","journal-title":"Semin. Arthritis Rheum."},{"key":"36340_CR23","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1136\/ard.2004.022871","volume":"64","author":"AP Cairns","year":"2005","unstructured":"Cairns, A. P., Wright, S. A., Taggart, A. J., Coward, S. M. & Wright, G. D. An open study of pulse pamidronate treatment in severe ankylosing spondylitis, and its effect on biochemical markers of bone turnover. Ann. Rheum. Dis. 64, 338\u2013339 (2005).","journal-title":"Ann. Rheum. Dis."},{"key":"36340_CR24","first-page":"S162","volume":"20","author":"H Haibel","year":"2002","unstructured":"Haibel, H., Braun, J. & Maksymowych, W. P. Bisphosphonates\u2013targeting bone in the treatment of spondyloarthritis. Clin. Exp. Rheumatol. 20, S162-166 (2002).","journal-title":"Clin. Exp. Rheumatol."},{"key":"36340_CR25","first-page":"144","volume":"28","author":"WP Maksymowych","year":"2001","unstructured":"Maksymowych, W. P. et al. Clinical and radiological amelioration of refractory peripheral spondyloarthritis by pulse intravenous pamidronate therapy. J. Rheumatol. 28, 144\u2013155 (2001).","journal-title":"J. Rheumatol."},{"key":"36340_CR26","doi-asserted-by":"publisher","first-page":"1211","DOI":"10.1002\/art.41667","volume":"73","author":"A Sepriano","year":"2021","unstructured":"Sepriano, A. et al. Tumor necrosis factor inhibitors reduce spinal radiographic progression in patients with radiographic axial spondyloarthritis: A longitudinal analysis from the alberta prospective cohort. Arthritis Rheumatol. 73, 1211\u20131219 (2021).","journal-title":"Arthritis Rheumatol."},{"key":"36340_CR27","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1002\/art.37704","volume":"65","author":"N Yeremenko","year":"2013","unstructured":"Yeremenko, N. et al. Disease-specific and inflammation-independent stromal alterations in spondylarthritis synovitis. Arthritis Rheum. 65, 174\u2013185 (2013).","journal-title":"Arthritis Rheum."},{"key":"36340_CR28","doi-asserted-by":"publisher","first-page":"718","DOI":"10.1002\/art.23290","volume":"58","author":"B Vandooren","year":"2008","unstructured":"Vandooren, B., Cantaert, T., Noordenbos, T., Tak, P. P. & Baeten, D. The abundant synovial expression of the RANK\/RANKL\/Osteoprotegerin system in peripheral spondylarthritis is partially disconnected from inflammation. Arthritis Rheum. 58, 718\u2013729 (2008).","journal-title":"Arthritis Rheum."},{"key":"36340_CR29","doi-asserted-by":"publisher","first-page":"1759720X2211003","DOI":"10.1177\/1759720X221100301","volume":"14","author":"TH Lee","year":"2022","unstructured":"Lee, T. H. et al. Age-stratified trends in the progression of spinal radiographic damage in patients with ankylosing spondylitis: A longitudinal study. Ther. Adv. Musculoskelet. Dis. 14, 1759720X221100301 (2022).","journal-title":"Ther. Adv. Musculoskelet. Dis."},{"key":"36340_CR30","doi-asserted-by":"crossref","first-page":"2645","DOI":"10.1002\/art.38070","volume":"65","author":"N Haroon","year":"2013","unstructured":"Haroon, N. et al. The impact of tumor necrosis factor \u03b1 inhibitors on radiographic progression in ankylosing spondylitis. Arthritis Rheum. 65, 2645\u20132654 (2013).","journal-title":"Arthritis Rheum."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-36340-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-36340-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-36340-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,12,14]],"date-time":"2023-12-14T12:42:25Z","timestamp":1702557745000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-36340-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6,5]]},"references-count":30,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["36340"],"URL":"https:\/\/doi.org\/10.1038\/s41598-023-36340-9","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-2366180\/v1","asserted-by":"object"}]},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,6,5]]},"assertion":[{"value":"11 December 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 June 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 June 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"9093"}}